Literature DB >> 28351624

HLA-A*31:01 and lamotrigine-induced severe cutaneous adverse drug reactions in a Korean population.

Byung-Keun Kim1, Jae-Woo Jung2, Tae-Bum Kim3, Yoon-Seok Chang1, Hae-Sim Park4, Jangsup Moon5, Soon-Tae Lee5, Keun-Hwa Jung5, Ki-Young Jung5, Kon Chu5, Sang Kun Lee5, Hye-Ryun Kang6, Heung-Woo Park7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28351624     DOI： 10.1016/j.anai.2017.02.011

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  9 in total

Review 1.  Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Authors:  Volker M Lauschke; Yitian Zhou; Magnus Ingelman-Sundberg
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 2.  An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.

Authors:  Chun-Bing Chen; Riichiro Abe; Ren-You Pan; Chuang-Wei Wang; Shuen-Iu Hung; Yi-Giien Tsai; Wen-Hung Chung
Journal:  J Immunol Res       Date:  2018-02-13       Impact factor: 4.818

3.  Genetic markers of severe cutaneous adverse reactions.

Authors:  Jae-Woo Jung; Jae-Yeol Kim; In-Won Park; Byoung-Whui Choi; Hye-Ryun Kang
Journal:  Korean J Intern Med       Date:  2018-06-22       Impact factor: 2.884

4.  Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics.

Authors:  Hossein Esmaeilzadeh; Shirin Farjadian; Soheila Alyasin; Hamid Nemati; Hesamodin Nabavizadeh; Elmira Esmaeilzadeh
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

Review 5.  Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions.

Authors:  Yueran Li; Pooja Deshpande; Rebecca J Hertzman; Amy M Palubinsky; Andrew Gibson; Elizabeth J Phillips
Journal:  Front Genet       Date:  2021-04-16       Impact factor: 4.599

6.  A new rapid titration protocol for lamotrigine that reduces the risk of skin rash.

Authors:  Yoonhyuk Jang; Jangsup Moon; Narae Kim; Tae-Joon Kim; Jin-Sun Jun; Yong-Won Shin; Hyeyeon Chang; Hye-Ryun Kang; Soon-Tae Lee; Keun-Hwa Jung; Kyung-Il Park; Ki-Young Jung; Kon Chu; Sang Kun Lee
Journal:  Epilepsia Open       Date:  2021-05-07

7.  Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.

Authors:  Elizabeth J Phillips; Chonlaphat Sukasem; Michelle Whirl-Carrillo; Daniel J Müller; Henry M Dunnenberger; Wasun Chantratita; Barry Goldspiel; Yuan-Tsong Chen; Bruce C Carleton; Alfred L George; Taisei Mushiroda; Teri Klein; Roseann S Gammal; Munir Pirmohamed
Journal:  Clin Pharmacol Ther       Date:  2018-02-02       Impact factor: 6.875

Review 8.  Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Authors:  Rebecca Pavlos; Katie D White; Celestine Wanjalla; Simon A Mallal; Elizabeth J Phillips
Journal:  Immunol Allergy Clin North Am       Date:  2017-11       Impact factor: 3.479

9.  HLA-A∗24:02 associated with lamotrigine-induced cutaneous adverse drug reactions: A systematic review and meta-analysis.

Authors:  Wanshu Li; Jie Wang; Hangjuan Lin; Gang Shen
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.